DK0834316T3 - Anvendelse af sulbutiamin til behandling af psykomotoriske eller psykointellektuelle problemer - Google Patents

Anvendelse af sulbutiamin til behandling af psykomotoriske eller psykointellektuelle problemer

Info

Publication number
DK0834316T3
DK0834316T3 DK97402320T DK97402320T DK0834316T3 DK 0834316 T3 DK0834316 T3 DK 0834316T3 DK 97402320 T DK97402320 T DK 97402320T DK 97402320 T DK97402320 T DK 97402320T DK 0834316 T3 DK0834316 T3 DK 0834316T3
Authority
DK
Denmark
Prior art keywords
sulbutiamine
psychomotor
treatment
psychointellectual
psycho
Prior art date
Application number
DK97402320T
Other languages
English (en)
Inventor
Helene Ollat
Ridant Alain Le
Laurent Perret
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK0834316T3 publication Critical patent/DK0834316T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preliminary Treatment Of Fibers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK97402320T 1996-10-04 1997-10-03 Anvendelse af sulbutiamin til behandling af psykomotoriske eller psykointellektuelle problemer DK0834316T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9612112A FR2754178B1 (fr) 1996-10-04 1996-10-04 Utilisation de la sulbutiamine pour l'obtention de compositions pharmaceutiques utiles dans le traitement de certains troubles psychomoteurs et psycho-intellectuels

Publications (1)

Publication Number Publication Date
DK0834316T3 true DK0834316T3 (da) 2002-08-05

Family

ID=9496363

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97402320T DK0834316T3 (da) 1996-10-04 1997-10-03 Anvendelse af sulbutiamin til behandling af psykomotoriske eller psykointellektuelle problemer

Country Status (17)

Country Link
US (1) US5863925A (da)
EP (1) EP0834316B1 (da)
JP (1) JP4234218B2 (da)
CN (1) CN1091370C (da)
AT (1) ATE216884T1 (da)
AU (1) AU716329B2 (da)
BR (1) BR9704964A (da)
CA (1) CA2217463C (da)
DE (1) DE69712287T2 (da)
DK (1) DK0834316T3 (da)
ES (1) ES2176642T3 (da)
FR (1) FR2754178B1 (da)
HU (1) HU227542B1 (da)
NO (1) NO313684B1 (da)
NZ (1) NZ328915A (da)
PT (1) PT834316E (da)
ZA (1) ZA978879B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA12541A (en) * 2001-01-31 2006-06-05 Pfizer Prod Inc Ether derivatives useful as inhibitors of PDE4 isozymes.
NZ530158A (en) * 2002-12-20 2005-11-25 Therakos Inc Irradiation chamber
US20070185141A1 (en) * 2006-02-09 2007-08-09 Tim Patterson Thiamine composition for enhancement of physical and mental energy, and related method
US9463186B2 (en) 2013-04-15 2016-10-11 Northwestern University Treatment for dopaminergic disorders

Also Published As

Publication number Publication date
NZ328915A (en) 2000-08-25
ZA978879B (en) 1998-04-17
CN1091370C (zh) 2002-09-25
HU9701606D0 (en) 1997-11-28
PT834316E (pt) 2002-08-30
DE69712287T2 (de) 2002-12-12
DE69712287D1 (de) 2002-06-06
ATE216884T1 (de) 2002-05-15
CA2217463A1 (fr) 1998-04-04
JP4234218B2 (ja) 2009-03-04
US5863925A (en) 1999-01-26
JPH10130151A (ja) 1998-05-19
FR2754178A1 (fr) 1998-04-10
NO974551D0 (no) 1997-10-02
ES2176642T3 (es) 2002-12-01
CA2217463C (fr) 2003-04-01
AU3992897A (en) 1998-04-09
AU716329B2 (en) 2000-02-24
CN1182588A (zh) 1998-05-27
EP0834316A1 (fr) 1998-04-08
HU227542B1 (en) 2011-08-29
HUP9701606A2 (hu) 1998-06-29
NO974551L (no) 1998-04-06
BR9704964A (pt) 1998-10-27
NO313684B1 (no) 2002-11-18
FR2754178B1 (fr) 2002-08-23
EP0834316B1 (fr) 2002-05-02
HUP9701606A3 (en) 1999-07-28

Similar Documents

Publication Publication Date Title
NO20001754L (no) Prostaglandinagonister og anvendelse derav for behandling av benforstyrrelser
DE3686975T2 (de) Zusammensetzung auf basis von glucomannanen und polyhydrischen alkoholen und daraus hergestellter film.
FI950909A (fi) Rasvahappojohdannaisia
BR9707922A (pt) Cafeína e clemastina para tratamento de distúrbios respiratórios
FI830523L (fi) Anti-inflammatoriska och/eller smaerta lindrande 2,3-diaryl-5-halotiofener
DK0834316T3 (da) Anvendelse af sulbutiamin til behandling af psykomotoriske eller psykointellektuelle problemer
LV11940A (lv) Melatonina pielietojums personu arstesanai kuras cies no zalu atkaribas
DK1133296T3 (da) Ny terapeutisk anvendelse af nicergolin
DK631989A (da) Anti-plakmiddel og/eller middel til behandling af lidelser i mundhulen
ATE238796T1 (de) Nukleosidderivative in kombinationspräparaten zur behandlung von hsv krankheiten
EE9700037A (et) Jäätmete töötlemise meetod ning meetodis kasutatav seadmestik
DE59711240D1 (de) Verwendung von flupirtin zur therapie und prophylaxe von myokardinfarkt, schockniere und schocklunge
IT233164Y1 (it) Brandina o cuccia pieghegole e/o smontabile.
DK0661058T3 (da) Anvendelse af bradykininantagonister til behandling af virussygdomme
DK0891778T3 (da) TCF-II til forebyggelse og/eller behandling af stråleinducerede lidelser
DE69109565T2 (de) Beatmungsgerät und verwendungsverfahren.
IT1302920B1 (it) Uso della propoli nel trattamento della vitiligine e della psoriasi.
KR970022507U (ko) 자동차의 착탈시 우산 수납장
DK0721781T3 (da) Reduktion af fedtvæv under anvendelse af kollagenase
ITMI962619A1 (it) Liso-fosfatidil-bis-fosfonati e tartronati utili nel trattamento del dismetabolismo osseo e lipidico
IT1297340B1 (it) Dispositivo e corredo per il tratamento dell'alitosi
KR960003794U (ko) 혈행작용을 촉진시키는 미용기구
KR950028146U (ko) 기포식 냉각 및 살균장치
ITTV970049A0 (it) Procedimento ed apparecchiatura per l'abbronzatura artificiale.
DE9413053U1 (de) Vorrichtung zur Kontrolle der Kreislauffunktion von gehfähigen Patienten